BioHarvest Sciences Inc.
BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC)(NASDAQ: BHST) is a leader in Botanical Synthesis, leveraging its patented technology process to grow plant-based molecules without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.
BioHarvest Sciences Inc. (BHSC)
SEDAR Information
Information d'entreprise
Capitalisation
Company Officers
Communiqués de presse
News release - delisting
News Release - November 15, 2024
Bulletins
2025-0211 - Radiation - BioHarvest Sciences Inc. (BHSC)
Le 13 février/February 2025
At the request of the company, BioHarvest Sciences Inc. will be delisted from the CSE effective market close on February 14, 2025.
BioHarvest Sciences will continue to trade on the Nasdaq.
For further in details please see the BioHarvest Sciences news release.
__________________________________________